Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis
Open Access
- 14 February 2015
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (6) , e226-e228
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosisJournal of Hepatology, 2015
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemiaBlood, 2014
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesBlood, 2014
- SomaticCALRMutations in Myeloproliferative Neoplasms with NonmutatedJAK2New England Journal of Medicine, 2013
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsNew England Journal of Medicine, 2013
- Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleedingJournal of Thrombosis and Haemostasis, 2013
- Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysisBlood, 2012
- Impaired fibrinolysis as a risk factor for Budd-Chiari syndromeBlood, 2010
- Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up StudyHepatology, 2010
- Etiology, Management, and Outcome of the Budd-Chiari SyndromeAnnals of Internal Medicine, 2009